{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=QT+Effects+in+Healthy+Volunteers&page=2", "query": { "condition": "QT Effects in Healthy Volunteers", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=QT+Effects+in+Healthy+Volunteers&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-07-24T18:07:38.080Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03985410", "title": "Study Evaluating the Effect of ETX2514 on Cardiac Repolarization in Healthy Male or Female Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Acinetobacter Baumannii-calcoaceticus Complex Infections" ], "interventions": [ { "name": "ETX2514", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "moxifloxacin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Entasis Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 32, "start_date": "2019-05-23", "completion_date": "2019-07-24", "has_results": false, "last_update_posted_date": "2019-08-30", "last_synced_at": "2026-07-24T18:07:38.080Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03985410" }, { "nct_id": "NCT00543062", "title": "Staccato Prochlorperazine Thorough QT/QTc", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Cardiotoxicity" ], "interventions": [ { "name": "Inhaled placebo", "type": "DRUG" }, { "name": "Oral placebo", "type": "DRUG" }, { "name": "Inhaled prochlorperazine 5 mg", "type": "DRUG" }, { "name": "Inhaled prochlorperazine 10 mg", "type": "DRUG" }, { "name": "Oral moxifloxacin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alexza Pharmaceuticals, Inc.", "sponsor_class": "UNKNOWN", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 48, "start_date": "2007-10", "completion_date": "2007-12", "has_results": true, "last_update_posted_date": "2019-03-11", "last_synced_at": "2026-07-24T18:07:38.080Z", "location_count": 1, "location_summary": "Evansville, Indiana", "locations": [ { "city": "Evansville", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT00543062" }, { "nct_id": "NCT02040987", "title": "AZD3293 Thorough QT Study in Healthy Male Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Alzheimer's Disease" ], "interventions": [ { "name": "AZD3293", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Moxifloxacin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "MALE", "summary": "18 Years to 55 Years · Male only" }, "enrollment_count": 52, "start_date": "2014-01", "completion_date": "2014-05", "has_results": false, "last_update_posted_date": "2014-07-03", "last_synced_at": "2026-07-24T18:07:38.080Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT02040987" }, { "nct_id": "NCT04688632", "title": "Thorough QT Study to Evaluate Ampreloxetine in Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Symptomatic Neurogenic Orthostatic Hypertension", "nOH" ], "interventions": [ { "name": "Ampreloxetine ", "type": "DRUG" }, { "name": "Ampreloxetine ", "type": "DRUG" }, { "name": "Ampreloxetine Placebo", "type": "DRUG" }, { "name": "Moxifloxacin", "type": "DRUG" }, { "name": "Moxifloxacin Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Theravance Biopharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 72, "start_date": "2021-01-18", "completion_date": "2021-03-26", "has_results": false, "last_update_posted_date": "2021-04-20", "last_synced_at": "2026-07-24T18:07:38.080Z", "location_count": 1, "location_summary": "Tempe, Arizona", "locations": [ { "city": "Tempe", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT04688632" }, { "nct_id": "NCT01986894", "title": "A Phase 1 QT Study in Healthy Male Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Clinical Pharmacology, Healthy Volunteer Study" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Pomalidomide", "type": "DRUG" }, { "name": "Moxifloxacin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Celgene", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "MALE", "summary": "18 Years to 50 Years · Male only" }, "enrollment_count": 72, "start_date": "2013-10-18", "completion_date": "2013-12-02", "has_results": false, "last_update_posted_date": "2019-11-12", "last_synced_at": "2026-07-24T18:07:38.080Z", "location_count": 1, "location_summary": "Austin, Texas", "locations": [ { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01986894" }, { "nct_id": "NCT01297062", "title": "A Safety Study to Assess the Effects of Therapeutic and Supratherapeutic Exenatide Concentrations on QT Interval in Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Subjects" ], "interventions": [ { "name": "Exenatide", "type": "DRUG" }, { "name": "Moxifloxacin", "type": "DRUG" }, { "name": "Placebo comparator", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 94, "start_date": "2011-02", "completion_date": "2011-05", "has_results": true, "last_update_posted_date": "2015-04-14", "last_synced_at": "2026-07-24T18:07:38.080Z", "location_count": 2, "location_summary": "Daytona Beach, Florida • Evansville, Indiana", "locations": [ { "city": "Daytona Beach", "state": "Florida" }, { "city": "Evansville", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT01297062" }, { "nct_id": "NCT05630274", "title": "A Study of Effect of Selpercatinib (LY3527723) on Corrected QT (QTc) Interval in Healthy Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Selpercatinib", "type": "DRUG" }, { "name": "Moxifloxacin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 32, "start_date": "2019-04-16", "completion_date": "2019-06-21", "has_results": true, "last_update_posted_date": "2025-09-18", "last_synced_at": "2026-07-24T18:07:38.080Z", "location_count": 1, "location_summary": "Tempe, Arizona", "locations": [ { "city": "Tempe", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT05630274" }, { "nct_id": "NCT02155205", "title": "A Thorough QT Study of Telotristat Etiprate", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "QT Interval" ], "interventions": [ { "name": "Telotristat etiprate", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Moxifloxacin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Lexicon Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 48, "start_date": "2014-05", "completion_date": null, "has_results": false, "last_update_posted_date": "2014-09-08", "last_synced_at": "2026-07-24T18:07:38.080Z", "location_count": 1, "location_summary": "Evansville, Indiana", "locations": [ { "city": "Evansville", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT02155205" }, { "nct_id": "NCT04898907", "title": "Study Developed to Evaluate the Effect of ANG-3777 on QT/QTc Interval", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteer" ], "interventions": [ { "name": "ANG-3777 (Therapeutic Dose)", "type": "DRUG" }, { "name": "ANG-3777 (Supra-therapeutic Dose)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Moxifloxacin Hydrochloride", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Angion Biomedica Corp", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 48, "start_date": "2021-06", "completion_date": "2021-09", "has_results": false, "last_update_posted_date": "2021-06-01", "last_synced_at": "2026-07-24T18:07:38.080Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04898907" }, { "nct_id": "NCT02365532", "title": "Effect of Oral GS-6615 on Dofetilide-Induced QT Prolongation, Safety, and Tolerability in Healthy Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Long QT Syndrome" ], "interventions": [ { "name": "GS-6615", "type": "DRUG" }, { "name": "Placebo to match GS-6615", "type": "DRUG" }, { "name": "Placebo to match dofetilide", "type": "DRUG" }, { "name": "Dofetilide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "18 Years to 40 Years" }, "enrollment_count": 60, "start_date": "2015-02", "completion_date": "2015-05", "has_results": false, "last_update_posted_date": "2015-05-20", "last_synced_at": "2026-07-24T18:07:38.080Z", "location_count": 1, "location_summary": "West Bend, Wisconsin", "locations": [ { "city": "West Bend", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT02365532" } ] }